Regulus Therapeutics
RGLS
$2.34
Share price
0.09%
Change (1 day)
91.97%
Change (1 year)
Categories
Regulus Therapeutics (RGLS) Fails to deliver data
Key failure to deliver metrics for Regulus Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $2.27 M
- Last 3 months FTD volume: $2.28 M
- Last year FTD volume: $2.36 M
Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022
Volume in USD (price x number of shares), data since 2022Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.28 M | 1404.33% |
| 2023 | $0.15 M | -85.22% |
| 2022 | $1.02 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $26.25 M | $54.4 M | 🇫🇷 France |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $0.14 M | $1.62 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.22 M | $43.68 M | 🇺🇸 USA |